Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Trastuzumab price philippines?How much does pataday cost?How much does allopurinol cost?Ribociclib fda approval date?Arazlo vs tazarotene?
See the DrugPatentWatch profile for evoxac
Evoxac (cevimeline) was approved by the U.S. FDA on January 11, 2000.
Evoxac (cevimeline) is prescribed for patients with xerostomia (dry mouth) associated with Sjögren’s syndrome.
DrugPatentWatch lists Evoxac (cevimeline) with an FDA approval date of January 11, 2000. [1]
Other Questions About Evoxac :